SNDX
Syndax Pharmaceuticals Inc
18.00$
+1.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | +257.1% | -38.6% | +161.0% | +89.4% | +20.8% | +49.3% | -5.3% | +12.2% | – | |
| – | +8,833.3% | -98.9% | +1,477,800.0% | -100.0% | +41,200.0% | +7.1% | +44.5% | +64.2% | -174.9% | – | +21.8% | – | |
| – | – | -101.1% | – | +257.1% | -38.6% | +149.4% | +91.5% | +19.3% | +60.0% | -11.2% | +11.8% | – | |
| – | +41.0% | +2.5% | -13.9% | +45.9% | -7.7% | -5.9% | +1.0% | -9.6% | +39.7% | -25.2% | +15.6% | – | |
| – | +155.6% | -47.8% | +26.2% | +7.0% | +21.2% | +8.9% | +6.8% | +2.5% | +11.2% | -24.7% | +10.5% | – | |
| – | +38.2% | +2.1% | -2.3% | +31.3% | +1.9% | -1.1% | +3.0% | -4.6% | +31.0% | -27.3% | +13.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -10.0% | -12.7% | -18.2% | -48.9% | +20,795.7% | +67.5% | -2.4% | +5.4% | +536.3% | -77.5% | +7.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.8% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.